Boston Scientific buying EndoChoice for $210M: 3 takeaways


Georgia-based EndoChoice will be purchased by Boston Scientific after the device company agreed to pay $210 million, the Boston Globe reports.

Here's what you should know.

1. Boston Scientific is going to $8-a-share for all of EndoChoice's outstanding shares.

2. Its expected the deal will close in the fourth quarter. EndoChoice will then become part of Boston Scientific's endoscopy business.

3. EndoChoice had $75 million in sales for 12 months on June 30.

More GI/endoscopy news:
Nanticoke Physician Network adds Dr. Ismet Lukolic: 4 things to know
Takeda named in Working Mother's top companies: 3 notes
GI physician Dr. Christopher Meyer out as Holzer Health System CEO: 5 things to know

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers